SCHEMBL7852207

SCHEMBL7852207

Cc1[nH]c(-c2ccc(S(C)(=O)=O)cc2)c(-c2ccc(F)cc2)c1COc1ccc(O)cc1

nearest known ligand 0.51

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 15/20 0.51
PTGS1 P23219 2/20 0.43
ESR1 P03372 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7855541 0.91 PTGS2 (0.51) PTGS2PTGS1
SCHEMBL7853463 0.90 PTGS2 (0.50) PTGS2PTGS1
SCHEMBL7857386 0.89 PTGS2 (0.47) PTGS2ESR1
SCHEMBL7856241 0.89 PTGS2 (0.47) PTGS2PTGS1
SCHEMBL7843040 0.82 PTGS2 (0.59) PTGS2PTGS1
SCHEMBL8823417 0.75 PTGS2 (0.66) PTGS2PTGS1
SCHEMBL7989345 0.72 PTGS2 (0.59) PTGS2PTGS1
SCHEMBL6711246 0.70 PTGS2 (0.83) PTGS2PTGS1
SCHEMBL7084896 0.69 PTGS2 (0.57) PTGS2PTGS1
SCHEMBL7085196 0.68 PTGS2 (0.59) PTGS2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1085845-A2 MULTIBINDING INHIBITORS OF CYCLOOXYGENASE-2 Advanced Medicine, Inc. (US) 2001-03-28 EP disclosed
EP-0989857-A4 NOVEL THERAPEUTIC AGENTS THAT MODULATE ENZYMATIC PROCESSES ADVANCED MEDICINE INC (US) 2001-01-17 EP disclosed
EP-0989857-A1 NOVEL THERAPEUTIC AGENTS THAT MODULATE ENZYMATIC PROCESSES Advanced Medicine, Inc. (US) 2000-04-05 EP disclosed
WO-1999063939-A2 MULTIBINDING INHIBITORS OF CYCLOOXYGENASE-2 ADVANCED MEDICINE, INC. (US) 1999-12-16 WO disclosed
WO-1999064037-A1 NOVEL THERAPEUTIC AGENTS THAT MODULATE ENZYMATIC PROCESSES ADVANCED MEDICINE, INC. (US) 1999-12-16 WO disclosed